AXON
Price
$609.90
Change
-$25.86 (-4.07%)
Updated
Dec 18, 04:59 PM (EDT)
76 days until earnings call
BBIO
Price
$26.60
Change
-$1.22 (-4.39%)
Updated
Dec 18, 04:07 PM (EDT)
64 days until earnings call
Ad is loading...

AXON vs BBIO

Header iconAXON vs BBIO Comparison
Open Charts AXON vs BBIOBanner chart's image
Axon Enterprise
Price$609.90
Change-$25.86 (-4.07%)
Volume$10.81K
CapitalizationN/A
BridgeBio Pharma
Price$26.60
Change-$1.22 (-4.39%)
Volume$3.54K
CapitalizationN/A
AXON vs BBIO Comparison Chart
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. BBIO commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a Hold and BBIO is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (AXON: $635.76 vs. BBIO: $27.82)
Brand notoriety: AXON and BBIO are both not notable
AXON represents the Aerospace & Defense, while BBIO is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 181% vs. BBIO: 73%
Market capitalization -- AXON: $48.48B vs. BBIO: $5.26B
AXON [@Aerospace & Defense] is valued at $48.48B. BBIO’s [@Biotechnology] market capitalization is $5.26B. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $179.44B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $14.36B. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 3 FA rating(s) are green whileBBIO’s FA Score has 1 green FA rating(s).

  • AXON’s FA Score: 3 green, 2 red.
  • BBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, AXON is a better buy in the long-term than BBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 3 TA indicator(s) are bullish while BBIO’s TA Score has 7 bullish TA indicator(s).

  • AXON’s TA Score: 3 bullish, 5 bearish.
  • BBIO’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, BBIO is a better buy in the short-term than AXON.

Price Growth

AXON (@Aerospace & Defense) experienced а -0.27% price change this week, while BBIO (@Biotechnology) price change was -4.20% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +1.68%. For the same industry, the average monthly price growth was +10.78%, and the average quarterly price growth was +24.34%.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

AXON is expected to report earnings on Mar 04, 2025.

BBIO is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Aerospace & Defense (+1.68% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($48.5B) has a higher market cap than BBIO($5.26B). AXON YTD gains are higher at: 146.104 vs. BBIO (-31.087). AXON has higher annual earnings (EBITDA): 408M vs. BBIO (-350.26M). AXON has more cash in the bank: 1.16B vs. BBIO (266M). AXON has less debt than BBIO: AXON (721M) vs BBIO (1.73B). AXON has higher revenues than BBIO: AXON (1.94B) vs BBIO (218M).
AXONBBIOAXON / BBIO
Capitalization48.5B5.26B922%
EBITDA408M-350.26M-116%
Gain YTD146.104-31.087-470%
P/E Ratio168.65N/A-
Revenue1.94B218M890%
Total Cash1.16B266M435%
Total Debt721M1.73B42%
FUNDAMENTALS RATINGS
AXON: Fundamental Ratings
AXON
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
2
SMR RATING
1..100
52
PRICE GROWTH RATING
1..100
1
P/E GROWTH RATING
1..100
29
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AXONBBIO
RSI
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
66%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SCHJ24.470.01
+0.04%
Schwab 1-5 Year Corporate Bond ETF
IHDG44.58-0.08
-0.18%
WisdomTree Intl Hdgd Qual Div Gr ETF
SIHY46.13-0.27
-0.58%
Harbor Scientific Alpha High-Yield ETF
SEA14.94-0.23
-1.50%
US Global Sea to Sky Cargo ETF
UMDD30.06-1.09
-3.51%
ProShares UltraPro MidCap400

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with ARGX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then ARGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
+0.40%
ARGX - BBIO
46%
Loosely correlated
+0.90%
AXON - BBIO
44%
Loosely correlated
-2.09%
ARRY - BBIO
43%
Loosely correlated
+6.01%
BPMC - BBIO
43%
Loosely correlated
+1.14%
PMN - BBIO
43%
Loosely correlated
-0.64%
More